S&P 500   3,002.59 (+0.55%)
DOW   26,792.65 (+0.08%)
QQQ   193.15 (+0.76%)
AAPL   240.83 (+1.87%)
FB   189.17 (+1.79%)
MSFT   138.00 (+0.43%)
GOOGL   1,244.43 (+0.00%)
AMZN   1,780.97 (+1.33%)
NVDA   195.46 (+2.61%)
MU   45.04 (+3.61%)
GE   8.81 (-1.67%)
TSLA   252.96 (-1.55%)
AMD   32.21 (+4.00%)
T   38.27 (-0.52%)
F   9.03 (-2.80%)
ACB   3.73 (+1.09%)
PRI   125.47 (+1.57%)
NFLX   276.47 (+0.42%)
BAC   30.97 (+2.01%)
GILD   65.17 (+0.40%)
DIS   130.57 (-0.24%)
S&P 500   3,002.59 (+0.55%)
DOW   26,792.65 (+0.08%)
QQQ   193.15 (+0.76%)
AAPL   240.83 (+1.87%)
FB   189.17 (+1.79%)
MSFT   138.00 (+0.43%)
GOOGL   1,244.43 (+0.00%)
AMZN   1,780.97 (+1.33%)
NVDA   195.46 (+2.61%)
MU   45.04 (+3.61%)
GE   8.81 (-1.67%)
TSLA   252.96 (-1.55%)
AMD   32.21 (+4.00%)
T   38.27 (-0.52%)
F   9.03 (-2.80%)
ACB   3.73 (+1.09%)
PRI   125.47 (+1.57%)
NFLX   276.47 (+0.42%)
BAC   30.97 (+2.01%)
GILD   65.17 (+0.40%)
DIS   130.57 (-0.24%)
Log in

ALPS Medical Breakthroughs ETF Stock Price, News & Analysis (NYSEARCA:SBIO)

$33.61
+0.75 (+2.28 %)
(As of 10/21/2019 02:08 PM ET)
Add
Today's Range
$33.00
Now: $33.61
$33.65
50-Day Range
$30.85
MA: $33.63
$36.37
52-Week Range
$25.49
Now: $33.61
$37.40
Volume12,309 shs
Average Volume37,108 shs
Market Capitalization$168.07 million
P/E RatioN/A
Dividend Yield2.34%
BetaN/A

Basic Details

Issuer Alps
Fund NameALPS Medical Breakthroughs ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:SBIO
Inception Date12/31/2014
Fund ManagerRyan Mischker, Andrew Hicks
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkPoliwogg Medical Breakthroughs Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$162.93 million
Average Daily Volume$33,996.10
Discount/Premium-0.05%

ETF Expenses

Management Fee0.50%
Other Expenses0.00%
Total Expenses0.50%
Fee Waiver0.00%
Net Expenses0.50%

Administrator, Advisor and Custodian

AdministratorALPS Fund Services, Inc.
AdvisorALPS Advisors, Inc.
CustodianState Street Bank and Trust Company
DistributorALPS Portfolio Solutions Distributor, Inc.
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerCantor Fitzgerald

Receive SBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for SBIO and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)
Currency Exposure of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)
Sector Exposure of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)
Industry Exposure of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Frequently Asked Questions

What is ALPS Medical Breakthroughs ETF's stock symbol?

ALPS Medical Breakthroughs ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "SBIO."

How often does ALPS Medical Breakthroughs ETF pay dividends? What is the dividend yield for ALPS Medical Breakthroughs ETF?

ALPS Medical Breakthroughs ETF declared an annual dividend on Thursday, December 20th. Shareholders of record on Friday, December 21st will be given a dividend of $0.7841 per share on Thursday, December 27th. This represents a yield of 2.88%. The ex-dividend date is Thursday, December 20th. View ALPS Medical Breakthroughs ETF's Dividend History.

Has ALPS Medical Breakthroughs ETF been receiving favorable news coverage?

News stories about SBIO stock have been trending somewhat positive on Monday, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. ALPS Medical Breakthroughs ETF earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for ALPS Medical Breakthroughs ETF.

What other stocks do shareholders of ALPS Medical Breakthroughs ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ALPS Medical Breakthroughs ETF investors own include ProShares Ultra Technology (ROM), Micron Technology (MU), Alibaba Group (BABA), Baidu (BIDU), JD.Com (JD), Lam Research (LRCX), Invesco QQQ Trust (QQQ), Blackstone Mortgage Trust (BXMT), Johnson & Johnson (JNJ) and Altria Group (MO).

Who are ALPS Medical Breakthroughs ETF's major shareholders?

ALPS Medical Breakthroughs ETF's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Wealthcare Advisory Partners LLC (0.04%).

Which major investors are selling ALPS Medical Breakthroughs ETF stock?

SBIO stock was sold by a variety of institutional investors in the last quarter, including Wealthcare Advisory Partners LLC.

How do I buy shares of ALPS Medical Breakthroughs ETF?

Shares of SBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is ALPS Medical Breakthroughs ETF's stock price today?

One share of SBIO stock can currently be purchased for approximately $33.61.

How big of a company is ALPS Medical Breakthroughs ETF?

ALPS Medical Breakthroughs ETF has a market capitalization of $168.07 million. View Additional Information About ALPS Medical Breakthroughs ETF.


MarketBeat Community Rating for ALPS Medical Breakthroughs ETF (NYSEARCA SBIO)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  27 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about ALPS Medical Breakthroughs ETF and other stocks. Vote "Outperform" if you believe SBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel